World journal of urology
-
World journal of urology · May 2016
ReviewWhat do we know about treatment sequencing of abiraterone, enzalutamide, and chemotherapy in metastatic castration-resistant prostate cancer?
To present a systematic review of the different therapeutic sequences in metastatic castration-resistant prostate cancer (mCRPC). ⋯ No study of high level of evidence is available to support any recommendation on sequential treatment for mCRPC. There are only clues that prospective clinical studies need to confirm.